MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-88005-4

Медицинская библиотека · Scientific reports · 2025

Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).

Araki Tomonori, Sonoda Yuki, Shimokawa Mototsugu, Otsuka Taiga, Hayashi Kohei, Honda Takuya, Nakao Kazuhiko, Shibuki Taro, Nakazawa Junichi, Arima Shiho, Miwa Keisuke, Okabe Yoshinobu, Koga Futa, Ueda Yujiro, Kubotsu Yoshihito, Shimokawa Hozumi, Takeshita Shigeyuki, Komori Azusa, Nishikawa Kazuo, Otsu Satoshi, Hosokawa Ayumu, Oda Hisanobu, Sakai Tatsunori, Arita Shuji, Kawahira Machiko, Taguchi Hiroki, Tsuneyoshi Kengo, Kawaguchi Yasunori, Fujita Toshihiro, Sakae Takahiro, Shirakawa Tsuyoshi, Mizuta Toshihiko, Mitsugi Kenji

СтатьяПеревод в очереди

Аннотация

The relationship between nanoliposomal irinotecan/fluorouracil/leucovorin (NFF) treatment outcomes and neutropenia in patients with pancreatic cancer has not been thoroughly examined. Thus, we conducted a retrospective analysis of data from patients with pancreatic cancer who were treated with NFF to investigate this relationship. Neutropenia was assessed according to the Common Terminology Criteria for Adverse Events across three cutoffs: A (grade 0 versus grade 1-4), B (grades 0-1 versus 2-4), and C (grades 0-2 versus 3-4). The primary endpoint was overall survival (OS), and the secondary endpoints were overall response rate, progression-free survival (PFS), and relative dose intensity. Of the 161 patients, 93, 8, 22, 30, and 8 patients had neutropenia of grades 0, 1, 2, 3, and 4, respectively. The overall response rates differed significantly at cutoff C (p = 0.02), with the odds ratio for cutoff C being the highest, followed by cutoffs B and A. Significant differences in OS were observed at cutoffs A (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.44-0.94; p = 0.02) and B (HR, 0.63; 95% CI, 0.43-0.92, p = 0.02). Similarly, PFS showed significant differences at cutoffs A and B (p < 0.01). NFF-induced neutropenia can be a useful prognostic factor for patients with pancreatic cancer.

Для цитирования: Araki Tomonori, Sonoda Yuki, Shimokawa Mototsugu, Otsuka Taiga, Hayashi Kohei, Honda Takuya, Nakao Kazuhiko, Shibuki Taro, Nakazawa Junichi, Arima Shiho, Miwa Keisuke, Okabe Yoshinobu, Koga Futa, Ueda Yujiro, Kubotsu Yoshihito, Shimokawa Hozumi, Takeshita Shigeyuki, Komori Azusa, Nishikawa Kazuo, Otsu Satoshi, Hosokawa Ayumu, Oda Hisanobu, Sakai Tatsunori, Arita Shuji, Kawahira Machiko, Taguchi Hiroki, Tsuneyoshi Kengo, Kawaguchi Yasunori, Fujita Toshihiro, Sakae Takahiro, Shirakawa Tsuyoshi, Mizuta Toshihiko, Mitsugi Kenji. Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301).. Scientific reports. 2025. DOI: 10.1038/s41598-025-88005-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.